Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: A comparative study

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 4, 2007, Pages 297-302

  Pamuk, Gülsüm Emel ^a,b   Turgut, Burhan ^a   Pamuk, Ömer Nuri ^a   Vural, Özden ^a   Demir, Muzaffer ^a   Çakr, Necati ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Platelet activation; Platelet microparticles; Platelet P selectin; Platelet monocyte complexes; Platelet neutrophil complexes; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; ILOPROST; PADGEM PROTEIN;

ADULT; ANTICOAGULANT THERAPY; ANTIGEN EXPRESSION; ARTICLE; AUTOINFLAMMATORY DISEASE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UTILIZATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; LYMPHOCYTE COUNT; MALE; MICROVASCULAR ISCHEMIA; MONOCYTE; NEUTROPHIL; PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; ULCER;

ADULT; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 34247866412     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328010bd05     Document Type: Article

References (26)

1. Herrick . Pathogenesis of Raynaud's phenomenon. Rheumatology 2005; 44:587-596.
2. Kaheleh B, Matucci-Cerinic M. Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 1995; 38:1-4.
3. Lau CS, McLaren M, Saniabadi A, Belch JJF. Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis. Scand J Rheumatol 1993; 22:97-101.
4. Silveri F, De Angelis R, Poggi A, Muti S, Bonapace G, Argentati F, et al. Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis. Scand J Rheumatol 2001; 30:290-296.
5. Goodfield MJ, Orchard MA, Rowell NR. Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis. Br J Haematol 1993; 84:675-680.
6. Villmow T, Kemkes-Matthes B, Matzdorff AC. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thrombosis Res 2003; 108:139-145.
7. Andre P. P-selectin in haemostasis. Br J Haematol 2004; 126:298-306.
8. Katopodis JN, Kolodny L, Jy W, Horstman LL, De Marchena EJ, Tao JG, et al. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997; 54:95-101.
9. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leukocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001; 115:451-459.
10. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002; 46:1498-1503.
11. 2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. J Rheumatol 2004; 31:2347-2355.
12. McCabe DJH, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, et al. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004; 125:777-787.
13. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38:1002-1006.
14. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997; 100:S97-S103.
15. Yamamoto T, Hartmann K, Eckes B, Krieg T. Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis. J Dermatol Sci 2001; 26:106-111.
16. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, et al. Induction of cytokine expression in leukocytes by binding thrombin-stimulated platelets. Circulation 1997; 95:2387-2394.
17. Lau CS, Bridges AB, Muir A, Scott N, Bancroft A, Belch JJF. Further evidence of increased polymorphnuclear cell activity in patients with Raynaud's phenomenon. Br J Rheumatol 1992; 31:375-380.
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-590.
19. Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P, et al. Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Group. Br J Rheumatol 1993; 32:357-361.
20. Krueger LA, Barnard MR, Frelinger AL, Furman MI, Michelson AD. Immunophenotypic analysis of platelets. In: Robinson JP, Darzynkiewicz Z, Dean PN, Dresiler LG, Rabinovitch PS, Stewart CC, Tanke HJ, Wheeless MC, editors. Current protocols in cytometry, 1st ed. New York: John Wiley & Sons, Inc.; 1997. pp. 6.10.1-6.10.17.
21. Ates A, Kinikli G, Turgay M, Duman M. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand J Immunol 2004; 59:315-320.
22. Herrick AL, Illingworth K, Blann A, Hay CR, Hollis S, Jayson MI. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis 1996; 55:122-127.
23. Gemmell CH, Ramirez SM, Yeo EL, Sefton MV. Platelet activation in whole blood by artificial surfaces: identification of platelet-derived microparticles and activated platelet binding to leukocytes as material-induced activation events. J Lab Clin Med 1995; 125:276-287.
24. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96:170-175.
25. Nagahama M, Nomura S, Ozaki Y, Yoshimura C, Kagawa H, Fukuhara S. Platelet activation and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity 2001; 33:85-94.
26. Magliano M, Isenberg DA, Hillson J. Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 2002; 46:1997-2009.